首页 > 最新文献

The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi最新文献

英文 中文
A Case of Esophageal MALT Lymphoma Mimicking a Subepithelial Tumor. 一例模仿上皮下肿瘤的食管 MALT 淋巴瘤病例
IF 0.6 Q3 Medicine Pub Date : 2024-04-25 DOI: 10.4166/kjg.2024.021
Ha Eun Lee, Gwang Ha Kim, Min Ji Kim, Kyung Bin Kim, Dong Chan Joo, Hye Kyung Jeon, M. Lee, B. Lee
Mucosa-associated lymphoid tissue (MALT) lymphoma, also known as extranodal marginal zone lymphoma, is a low-grade B-cell lymphoma that can develop in the mucosal layer of various organs, including the gastrointestinal tract, salivary glands, lungs, and skin. The most common site is the gastrointestinal tract, particularly the stomach. On the other hand, primary esophageal lymphomas are extremely rare. MALT lymphomas can undergo histological transformation into more aggressive B-cell lymphomas, such as diffuse large B-cell lymphoma, resulting in a poor prognosis. This paper reports a rare case of primary esophageal MALT lymphoma mimicking a subepithelial tumor located in the lower esophagus that was treated successfully with radiotherapy. MALT lymphoma should be included in a differential diagnosis when subepithelial tumors are found in the esophagus, particularly if endoscopic ultrasonography reveals the tumor to be located in the deep mucosal and submucosal layers. Following the precise diagnosis, accurate staging and appropriate treatment are crucial. Regular follow-up is necessary to assess the possibility of recurrence or transformation to high-grade lymphoma.
粘膜相关淋巴组织(MALT)淋巴瘤又称结外边缘区淋巴瘤,是一种低级别B细胞淋巴瘤,可发生在各种器官的粘膜层,包括胃肠道、唾液腺、肺和皮肤。最常见的部位是胃肠道,尤其是胃。另一方面,原发性食管淋巴瘤则极为罕见。MALT 淋巴瘤可在组织学上转化为更具侵袭性的 B 细胞淋巴瘤,如弥漫大 B 细胞淋巴瘤,导致预后不良。本文报告了一例罕见的原发性食管 MALT 淋巴瘤,该淋巴瘤模仿位于食管下段的上皮下肿瘤,通过放疗成功治愈。当发现食管上皮下肿瘤时,尤其是当内镜超声检查发现肿瘤位于粘膜深层和粘膜下层时,应将 MALT 淋巴瘤列入鉴别诊断。精确诊断后,准确的分期和适当的治疗至关重要。有必要进行定期随访,以评估复发或转化为高级别淋巴瘤的可能性。
{"title":"A Case of Esophageal MALT Lymphoma Mimicking a Subepithelial Tumor.","authors":"Ha Eun Lee, Gwang Ha Kim, Min Ji Kim, Kyung Bin Kim, Dong Chan Joo, Hye Kyung Jeon, M. Lee, B. Lee","doi":"10.4166/kjg.2024.021","DOIUrl":"https://doi.org/10.4166/kjg.2024.021","url":null,"abstract":"Mucosa-associated lymphoid tissue (MALT) lymphoma, also known as extranodal marginal zone lymphoma, is a low-grade B-cell lymphoma that can develop in the mucosal layer of various organs, including the gastrointestinal tract, salivary glands, lungs, and skin. The most common site is the gastrointestinal tract, particularly the stomach. On the other hand, primary esophageal lymphomas are extremely rare. MALT lymphomas can undergo histological transformation into more aggressive B-cell lymphomas, such as diffuse large B-cell lymphoma, resulting in a poor prognosis. This paper reports a rare case of primary esophageal MALT lymphoma mimicking a subepithelial tumor located in the lower esophagus that was treated successfully with radiotherapy. MALT lymphoma should be included in a differential diagnosis when subepithelial tumors are found in the esophagus, particularly if endoscopic ultrasonography reveals the tumor to be located in the deep mucosal and submucosal layers. Following the precise diagnosis, accurate staging and appropriate treatment are crucial. Regular follow-up is necessary to assess the possibility of recurrence or transformation to high-grade lymphoma.","PeriodicalId":22736,"journal":{"name":"The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi","volume":"59 9","pages":"157-162"},"PeriodicalIF":0.6,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140656058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between Atherosclerosis and High-Risk Colorectal Adenomas based on Cardio-Ankle Vascular Index and Ankle-Brachial Index. 基于心-踝血管指数和踝-肱指数的动脉粥样硬化与高风险结直肠腺瘤之间的关系
IF 0.6 Q3 Medicine Pub Date : 2024-04-25 DOI: 10.4166/kjg.2024.003
Jung Ho Lee, Hyunseok Cho, Sang Hoon Lee, Sung Joon Lee, C. Kang, Dae Hee Choi, Jin Myung Park, Seung-Joo Nam, Tae Suk Kim, Ji Hyun Kim, Sung Chul Park
Background/AimsColorectal adenomas are precancerous lesions that may lead to colorectal cancer. Recent studies have shown that colorectal adenomas are associated with atherosclerosis. The cardio-ankle vascular index (CAVI) and ankle-brachial index (ABI) are noninvasive methods for evaluating atherosclerosis. This study examined the association between atherosclerosis and high-risk colorectal adenomas based on the CAVI and ABI.MethodsThe data of patients aged ≥50 years who had a colonoscopy and CAVI and ABI measurements from August 2015 to December 2021 at the Kangwon National University Hospital were analyzed retrospectively. After the colonoscopy, subjects were divided into no, overall, and high-risk (size ≥1 cm, high-grade dysplasia or villous adenoma, three or more adenomas) adenoma groups based on the pathology findings. The data were subjected to univariate and multivariate logistic regression analyses.ResultsAmong the 1,164 subjects, adenomas and high-risk adenomas were found in 613 (52.6%) and 118 (10.1%) patients, respectively. The rate of positive ABI (<0.9) and positive CAVI (≥9.0) were significantly higher in the high-risk adenoma group (22.0% and 55.9%) than in the no adenoma (12.3% and 39.6%) and the overall adenoma group (15.7% and 44.0%) (p=0.008 and p=0.006, respectively). Multivariate analysis revealed a positive CAVI and smoking status to be significantly associated with high-risk adenoma with an odds ratio of 1.595 (95% confidence interval 1.055-2.410, p=0.027) and 1.579 (1.072-2.324, p=0.021), respectively.ConclusionsIn this study, a significant correlation between positive CAVI and high-risk adenomas was observed. Therefore, CAVI may be a significant predictor for high-risk colorectal adenoma.
背景/目的大肠腺瘤是可能导致大肠癌的癌前病变。最近的研究表明,大肠腺瘤与动脉粥样硬化有关。心-踝血管指数(CAVI)和踝-肱指数(ABI)是评估动脉粥样硬化的无创方法。本研究根据 CAVI 和 ABI 研究了动脉粥样硬化与高危大肠腺瘤之间的关联。方法回顾性分析了 2015 年 8 月至 2021 年 12 月期间在江原大学医院接受结肠镜检查并测量 CAVI 和 ABI 的年龄≥50 岁患者的数据。结肠镜检查后,根据病理结果将受试者分为无腺瘤组、总体腺瘤组和高风险(大小≥1厘米、高级别发育不良或绒毛状腺瘤、三个或三个以上腺瘤)腺瘤组。结果在 1 164 名受试者中,发现腺瘤和高危腺瘤的患者分别为 613 人(52.6%)和 118 人(10.1%)。高危腺瘤组(22.0% 和 55.9%)的 ABI 阳性率(<0.9)和 CAVI 阳性率(≥9.0)明显高于无腺瘤组(12.3% 和 39.6%)和腺瘤总体组(15.7% 和 44.0%)(分别为 p=0.008 和 p=0.006)。多变量分析显示,CAVI 阳性和吸烟状态与高危腺瘤显著相关,其几率比分别为 1.595(95% 置信区间 1.055-2.410,p=0.027)和 1.579(1.072-2.324,p=0.021)。因此,CAVI 可能是高危大肠腺瘤的重要预测指标。
{"title":"Association between Atherosclerosis and High-Risk Colorectal Adenomas based on Cardio-Ankle Vascular Index and Ankle-Brachial Index.","authors":"Jung Ho Lee, Hyunseok Cho, Sang Hoon Lee, Sung Joon Lee, C. Kang, Dae Hee Choi, Jin Myung Park, Seung-Joo Nam, Tae Suk Kim, Ji Hyun Kim, Sung Chul Park","doi":"10.4166/kjg.2024.003","DOIUrl":"https://doi.org/10.4166/kjg.2024.003","url":null,"abstract":"Background/Aims\u0000Colorectal adenomas are precancerous lesions that may lead to colorectal cancer. Recent studies have shown that colorectal adenomas are associated with atherosclerosis. The cardio-ankle vascular index (CAVI) and ankle-brachial index (ABI) are noninvasive methods for evaluating atherosclerosis. This study examined the association between atherosclerosis and high-risk colorectal adenomas based on the CAVI and ABI.\u0000\u0000\u0000Methods\u0000The data of patients aged ≥50 years who had a colonoscopy and CAVI and ABI measurements from August 2015 to December 2021 at the Kangwon National University Hospital were analyzed retrospectively. After the colonoscopy, subjects were divided into no, overall, and high-risk (size ≥1 cm, high-grade dysplasia or villous adenoma, three or more adenomas) adenoma groups based on the pathology findings. The data were subjected to univariate and multivariate logistic regression analyses.\u0000\u0000\u0000Results\u0000Among the 1,164 subjects, adenomas and high-risk adenomas were found in 613 (52.6%) and 118 (10.1%) patients, respectively. The rate of positive ABI (<0.9) and positive CAVI (≥9.0) were significantly higher in the high-risk adenoma group (22.0% and 55.9%) than in the no adenoma (12.3% and 39.6%) and the overall adenoma group (15.7% and 44.0%) (p=0.008 and p=0.006, respectively). Multivariate analysis revealed a positive CAVI and smoking status to be significantly associated with high-risk adenoma with an odds ratio of 1.595 (95% confidence interval 1.055-2.410, p=0.027) and 1.579 (1.072-2.324, p=0.021), respectively.\u0000\u0000\u0000Conclusions\u0000In this study, a significant correlation between positive CAVI and high-risk adenomas was observed. Therefore, CAVI may be a significant predictor for high-risk colorectal adenoma.","PeriodicalId":22736,"journal":{"name":"The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi","volume":"16 3","pages":"143-149"},"PeriodicalIF":0.6,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140656012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of the Efficacy of 12-day Concomitant Quadruple Therapy versus 14-day High dose Dual Therapy as a First-line H. pylori Eradication Regimen. 12 天四联疗法与 14 天大剂量双联疗法作为一线幽门螺杆菌根除方案的疗效比较。
IF 0.6 Q3 Medicine Pub Date : 2024-04-25 DOI: 10.4166/kjg.2024.012
Seyed Mohammad Valizadeh Toosi, Sahar Feyzi, Arash Kazemi
Background/AimsHelicobacter pylori (H. pylori) is the most prevalent infection in the world and is strongly associated with gastric adenocarcinoma, lymphoma and gastric or duodenal ulcers. Different regimens have been used for H. pylori eradication. We aimed to compare the efficacy of two different regimens as first-line H. pylori eradication regimens, in an area with high antibiotic resistance.MethodsIn this RCT, we assigned 223 patients with H. pylori infection, who were naïve to treatment. They were randomly divided into two groups to receive either 12-day concomitant quadruple therapy (consisting of pantoprazole 40 mg, amoxicillin 1 g, clarithromycin 500 mg, and metronidazole 500 mg every 12 hours) or 14-day high dose dual therapy (consisting of esomeprazole 40 mg and amoxicillin 1 g TDS). H. pylori eradication was assessed eight weeks after the end of treatment.ResultsH. pylori eradication rate by PP analysis for 12-day concomitant quadruple therapy and 14-day high dose dual therapy were 90.4% and 79.1%, respectively (p=0.02). According to ITT analysis, the eradication rates were 86.2% and 76.3%, respectively (p=0.06). Adverse drug reactions were 12.3% in high dose dual therapy and 36.8% in concomitant quadruple therapy (p<0.001).ConclusionsTwelve-day concomitant therapy seems to be an acceptable regimen for first-line H. pylori eradication in Iran, a country with a high rate of antibiotic resistance. Although, high dose dual therapy did not result in an ideal eradication rate, but it had fewer drug side effects than the 12-day concomitant regimen.
背景/目的幽门螺杆菌(H. pylori)是世界上最普遍的感染,与胃腺癌、淋巴瘤、胃或十二指肠溃疡密切相关。根除幽门螺杆菌的方法多种多样。我们的目的是在抗生素耐药性较高的地区,比较两种不同方案作为一线幽门螺杆菌根除方案的疗效。他们被随机分为两组,分别接受为期 12 天的四联疗法(包括每 12 小时一次的泮托拉唑 40 毫克、阿莫西林 1 克、克拉霉素 500 毫克和甲硝唑 500 毫克)或为期 14 天的大剂量双联疗法(包括埃索美拉唑 40 毫克和阿莫西林 1 克 TDS)。结果 通过PP分析,12天同时四联疗法和14天大剂量双联疗法的幽门螺杆菌根除率分别为90.4%和79.1%(P=0.02)。根据ITT分析,根除率分别为86.2%和76.3%(P=0.06)。结论在伊朗这个抗生素耐药率较高的国家,12 天联合治疗似乎是一线根除幽门螺杆菌的可接受方案。虽然大剂量双联疗法的根除率并不理想,但其药物副作用却少于12天同时治疗方案。
{"title":"Comparison of the Efficacy of 12-day Concomitant Quadruple Therapy versus 14-day High dose Dual Therapy as a First-line H. pylori Eradication Regimen.","authors":"Seyed Mohammad Valizadeh Toosi, Sahar Feyzi, Arash Kazemi","doi":"10.4166/kjg.2024.012","DOIUrl":"https://doi.org/10.4166/kjg.2024.012","url":null,"abstract":"Background/Aims\u0000Helicobacter pylori (H. pylori) is the most prevalent infection in the world and is strongly associated with gastric adenocarcinoma, lymphoma and gastric or duodenal ulcers. Different regimens have been used for H. pylori eradication. We aimed to compare the efficacy of two different regimens as first-line H. pylori eradication regimens, in an area with high antibiotic resistance.\u0000\u0000\u0000Methods\u0000In this RCT, we assigned 223 patients with H. pylori infection, who were naïve to treatment. They were randomly divided into two groups to receive either 12-day concomitant quadruple therapy (consisting of pantoprazole 40 mg, amoxicillin 1 g, clarithromycin 500 mg, and metronidazole 500 mg every 12 hours) or 14-day high dose dual therapy (consisting of esomeprazole 40 mg and amoxicillin 1 g TDS). H. pylori eradication was assessed eight weeks after the end of treatment.\u0000\u0000\u0000Results\u0000H. pylori eradication rate by PP analysis for 12-day concomitant quadruple therapy and 14-day high dose dual therapy were 90.4% and 79.1%, respectively (p=0.02). According to ITT analysis, the eradication rates were 86.2% and 76.3%, respectively (p=0.06). Adverse drug reactions were 12.3% in high dose dual therapy and 36.8% in concomitant quadruple therapy (p<0.001).\u0000\u0000\u0000Conclusions\u0000Twelve-day concomitant therapy seems to be an acceptable regimen for first-line H. pylori eradication in Iran, a country with a high rate of antibiotic resistance. Although, high dose dual therapy did not result in an ideal eradication rate, but it had fewer drug side effects than the 12-day concomitant regimen.","PeriodicalId":22736,"journal":{"name":"The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi","volume":"70 18","pages":"150-156"},"PeriodicalIF":0.6,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140655239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Metastatic Melanoma of the Common Bile Duct Presented with Dyspepsia. 胆总管转移性黑色素瘤伴有消化不良。
IF 0.6 Q3 Medicine Pub Date : 2024-04-25 DOI: 10.4166/kjg.2024.011
O. F. Cetiner, Huseyin Emre Dundar, Sinem Kantarcioglu-Coskun, Serkan Torun, S. Tokmak
Malignant melanoma (MM) is an aggressive tumor that can metastasize to any organ, but biliary tract metastasis is scarce. We describe a very rare case of MM metastasis to the common bile duct (CBD), presented with only dyspeptic symptoms. The patient had mildly elevated alkaline phosphatase and gamma-glutamyl transferase levels. Magnetic resonance cholangiopancreatography demonstrated a dilated common bile duct with a distal stricture. The MM diagnosis was established with the ampulla of Vater biopsy specimens obtained by endoscopic retrograde cholangiopancreatography (ERCP), and the patient's symptoms were resolved after biliary stenting. Both primary CBD cancer and other cancer types like MM that metastasize to CBD can cause obstruction and can be manifested only by dyspeptic symptoms. MM metastasis to CBD can cause obstruction manifested only by dyspeptic symptoms without obstructive jaundice. ERCP can be employed as a promising option for treatment and diagnosis. New-onset dyspeptic symptoms in patients with a history of MM should be investigated thoroughly, especially in the context of biliary metastasis.
恶性黑色素瘤(MM)是一种侵袭性肿瘤,可转移至任何器官,但胆道转移却很少见。我们描述了一例非常罕见的MM转移至胆总管(CBD)的病例,患者仅表现为消化不良症状。患者的碱性磷酸酶和γ-谷氨酰转移酶水平轻度升高。磁共振胰胆管造影显示胆总管扩张,远端狭窄。通过内镜逆行胰胆管造影术(ERCP)获得的瓦特瓿活检标本确定了MM诊断,胆道支架术后患者症状缓解。原发性 CBD 癌症和转移至 CBD 的其他癌症类型(如 MM)均可导致梗阻,并仅表现为消化不良症状。转移到CBD的MM可引起梗阻,仅表现为消化不良症状,而无梗阻性黄疸。ERCP是一种很有前景的治疗和诊断方法。对有MM病史的患者新出现的消化不良症状应进行彻底检查,尤其是在胆道转移的情况下。
{"title":"Metastatic Melanoma of the Common Bile Duct Presented with Dyspepsia.","authors":"O. F. Cetiner, Huseyin Emre Dundar, Sinem Kantarcioglu-Coskun, Serkan Torun, S. Tokmak","doi":"10.4166/kjg.2024.011","DOIUrl":"https://doi.org/10.4166/kjg.2024.011","url":null,"abstract":"Malignant melanoma (MM) is an aggressive tumor that can metastasize to any organ, but biliary tract metastasis is scarce. We describe a very rare case of MM metastasis to the common bile duct (CBD), presented with only dyspeptic symptoms. The patient had mildly elevated alkaline phosphatase and gamma-glutamyl transferase levels. Magnetic resonance cholangiopancreatography demonstrated a dilated common bile duct with a distal stricture. The MM diagnosis was established with the ampulla of Vater biopsy specimens obtained by endoscopic retrograde cholangiopancreatography (ERCP), and the patient's symptoms were resolved after biliary stenting. Both primary CBD cancer and other cancer types like MM that metastasize to CBD can cause obstruction and can be manifested only by dyspeptic symptoms. MM metastasis to CBD can cause obstruction manifested only by dyspeptic symptoms without obstructive jaundice. ERCP can be employed as a promising option for treatment and diagnosis. New-onset dyspeptic symptoms in patients with a history of MM should be investigated thoroughly, especially in the context of biliary metastasis.","PeriodicalId":22736,"journal":{"name":"The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi","volume":"33 15","pages":"163-166"},"PeriodicalIF":0.6,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140657409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Bile Acid Diarrhea]. [胆汁酸腹泻]。
IF 0.6 Q3 Medicine Pub Date : 2024-04-25 DOI: 10.4166/kjg.2023.119
Hee Jin Kim, Hyun Jin Kim
Diarrhea is a very common gastrointestinal symptom, and the presence of higher concentrations of bile acid in the colon leads to bile acid diarrhea (BAD). In BAD patients, a portion of bile from the small intestine that is normally controlled by enterohepatic circulation is present at a high concentration in the lumen of the large intestine, resulting in increased motility and secretion of the large intestine. The prevalence of BAD is estimated to be 1-2% of the general population, and it comprises one-third of the instances of diarrhea-predominant irritable bowel syndrome. The clinical symptoms of BAD include chronic diarrhea, increased frequency of defecation, urgency to defecate, fecal incontinence, and cramping abdominal pain. The pathophysiology of BAD has not yet been fully elucidated. However, recent studies have reported increased intestinal permeability, shortened intestinal transit time, and changes in the intestinal microbial community to be the possible causes of BAD. Although fecal and serum bile acid tests are widely used for diagnosis, new test methods that are non-invasive, inexpensive, and have high sensitivity and specificity are needed at various institutions to facilitate the diagnosis. The selenium homo-tauro-cholic acid (SeHCAT) test is the gold standard for BAD diagnosis and severity assessment. The validation of several other serum markers, such as 7-hydroxy-4-cholesten-3-one (serum 7αC4) and the fibroblast growth factor 19 (FGF19) for use in clinical practice is ongoing. Although bile acid sequestrants are the mainstay of treatment, the development of drugs that are more effective and have better compliance is required. Farnesoid X receptor (FXR) agonists are showing promising results.
腹泻是一种非常常见的胃肠道症状,结肠中存在较高浓度的胆汁酸会导致胆汁酸腹泻(BAD)。在 BAD 患者中,通常由肠肝循环控制的来自小肠的部分胆汁以高浓度存在于大肠腔内,导致大肠蠕动和分泌增加。据估计,肠易激综合征在普通人群中的发病率为 1%-2%,占以腹泻为主的肠易激综合征病例的三分之一。BAD 的临床症状包括慢性腹泻、排便次数增多、排便急迫、大便失禁和痉挛性腹痛。BAD 的病理生理学尚未完全阐明。不过,最近的研究报告称,肠道渗透性增加、肠道转运时间缩短和肠道微生物群落的变化可能是导致 BAD 的原因。尽管粪便和血清胆汁酸检测已被广泛用于诊断,但各机构仍需要无创、廉价、灵敏度和特异性高的新检测方法来促进诊断。硒均甲胆酸(SeHCAT)检测是诊断和评估 BAD 严重程度的金标准。其他几种血清标记物,如 7-羟基-4-胆甾烯-3-酮(血清 7αC4)和成纤维细胞生长因子 19(FGF19),在临床实践中的应用验证正在进行中。虽然胆汁酸螯合剂是治疗的主要手段,但仍需开发更有效、依从性更好的药物。法尼类固醇 X 受体(FXR)激动剂正显示出良好的效果。
{"title":"[Bile Acid Diarrhea].","authors":"Hee Jin Kim, Hyun Jin Kim","doi":"10.4166/kjg.2023.119","DOIUrl":"https://doi.org/10.4166/kjg.2023.119","url":null,"abstract":"Diarrhea is a very common gastrointestinal symptom, and the presence of higher concentrations of bile acid in the colon leads to bile acid diarrhea (BAD). In BAD patients, a portion of bile from the small intestine that is normally controlled by enterohepatic circulation is present at a high concentration in the lumen of the large intestine, resulting in increased motility and secretion of the large intestine. The prevalence of BAD is estimated to be 1-2% of the general population, and it comprises one-third of the instances of diarrhea-predominant irritable bowel syndrome. The clinical symptoms of BAD include chronic diarrhea, increased frequency of defecation, urgency to defecate, fecal incontinence, and cramping abdominal pain. The pathophysiology of BAD has not yet been fully elucidated. However, recent studies have reported increased intestinal permeability, shortened intestinal transit time, and changes in the intestinal microbial community to be the possible causes of BAD. Although fecal and serum bile acid tests are widely used for diagnosis, new test methods that are non-invasive, inexpensive, and have high sensitivity and specificity are needed at various institutions to facilitate the diagnosis. The selenium homo-tauro-cholic acid (SeHCAT) test is the gold standard for BAD diagnosis and severity assessment. The validation of several other serum markers, such as 7-hydroxy-4-cholesten-3-one (serum 7αC4) and the fibroblast growth factor 19 (FGF19) for use in clinical practice is ongoing. Although bile acid sequestrants are the mainstay of treatment, the development of drugs that are more effective and have better compliance is required. Farnesoid X receptor (FXR) agonists are showing promising results.","PeriodicalId":22736,"journal":{"name":"The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi","volume":"12 18","pages":"133-142"},"PeriodicalIF":0.6,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140657887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful Transcatheter Arterial Embolization of Abdominal Wall Hematoma from the Left Deep Circumflex Iliac Artery after Abdominal Paracentesis in a Patient with Liver Cirrhosis: Case Report and Literature Review. 肝硬化患者腹腔穿刺术后左侧深环髂动脉腹壁血肿经导管动脉栓塞术获得成功:病例报告和文献综述。
IF 0.6 Q3 Medicine Pub Date : 2024-04-25 DOI: 10.4166/kjg.2024.030
YOUNG-EUN Seo, C. Lim, JAE-WOONG Lim, Je Seong Kim, Hyung Hoon Oh, Keon-Young Ma, Ga-Ram You, Chan-Mook Im, Byung Chan Lee, Young-Eun Joo
The occurrence of an abdominal wall hematoma caused by abdominal paracentesis in patients with liver cirrhosis is rare. This paper presents a case of an abdominal wall hematoma caused by abdominal paracentesis in a 67-year-old woman with liver cirrhosis with a review of the relevant literature. Two days prior, the patient underwent abdominal paracentesis for symptom relief for refractory ascites at a local clinic. Upon admission, a physical examination revealed purpuric patches with swelling and mild tenderness in the left lower quadrant of the abdominal wall. Abdominal computed tomography revealed advanced liver cirrhosis with splenomegaly, tortuous dilatation of the para-umbilical vein, a large volume of ascites, and a large acute hematoma at the left lower quadrant of the abdominal wall. An external iliac artery angiogram showed the extravasation of contrast media from the left deep circumflex iliac artery. Embolization of the target arterial branches using N-butyl-2-cyanoacrylate was then performed, and the bleeding was stopped. The final diagnosis was an abdominal wall hematoma from the left deep circumflex iliac artery after abdominal paracentesis in a patient with liver cirrhosis.
肝硬化患者腹腔穿刺引起腹壁血肿的情况非常罕见。本文介绍了一例因腹腔穿刺引起腹壁血肿的病例,患者是一名 67 岁的女性肝硬化患者,并回顾了相关文献。两天前,患者因难治性腹水在当地诊所接受了腹腔穿刺术以缓解症状。入院时,体格检查发现患者腹壁左下腹有紫癜性斑块、肿胀和轻度压痛。腹部计算机断层扫描显示肝硬化晚期伴有脾肿大、脐旁静脉迂曲扩张、大量腹水以及腹壁左下象限的巨大急性血肿。髂外动脉造影显示造影剂从左侧髂深周动脉外渗。随后使用 N-丁基-2-氰基丙烯酸酯对目标动脉分支进行了栓塞,止住了出血。最终诊断为肝硬化患者腹腔穿刺术后左侧髂深周动脉引起的腹壁血肿。
{"title":"Successful Transcatheter Arterial Embolization of Abdominal Wall Hematoma from the Left Deep Circumflex Iliac Artery after Abdominal Paracentesis in a Patient with Liver Cirrhosis: Case Report and Literature Review.","authors":"YOUNG-EUN Seo, C. Lim, JAE-WOONG Lim, Je Seong Kim, Hyung Hoon Oh, Keon-Young Ma, Ga-Ram You, Chan-Mook Im, Byung Chan Lee, Young-Eun Joo","doi":"10.4166/kjg.2024.030","DOIUrl":"https://doi.org/10.4166/kjg.2024.030","url":null,"abstract":"The occurrence of an abdominal wall hematoma caused by abdominal paracentesis in patients with liver cirrhosis is rare. This paper presents a case of an abdominal wall hematoma caused by abdominal paracentesis in a 67-year-old woman with liver cirrhosis with a review of the relevant literature. Two days prior, the patient underwent abdominal paracentesis for symptom relief for refractory ascites at a local clinic. Upon admission, a physical examination revealed purpuric patches with swelling and mild tenderness in the left lower quadrant of the abdominal wall. Abdominal computed tomography revealed advanced liver cirrhosis with splenomegaly, tortuous dilatation of the para-umbilical vein, a large volume of ascites, and a large acute hematoma at the left lower quadrant of the abdominal wall. An external iliac artery angiogram showed the extravasation of contrast media from the left deep circumflex iliac artery. Embolization of the target arterial branches using N-butyl-2-cyanoacrylate was then performed, and the bleeding was stopped. The final diagnosis was an abdominal wall hematoma from the left deep circumflex iliac artery after abdominal paracentesis in a patient with liver cirrhosis.","PeriodicalId":22736,"journal":{"name":"The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi","volume":"25 21","pages":"167-171"},"PeriodicalIF":0.6,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140657798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Obesity and Colorectal Cancer]. [肥胖与结直肠癌]。
IF 0.6 Q3 Medicine Pub Date : 2023-08-25 DOI: 10.4166/kjg.2023.083
Jundeok Lee, Su Young Kim

The prevalence of obesity has increased significantly worldwide, and this trend is likely to continue in the coming years. There is substantial evidence that obesity plays a crucial role in the development of colorectal cancer. Epidemiological data have consistently demonstrated a correlation between obesity and colorectal cancer. Insulin resistance, hyperinsulinemia, chronic inflammation, altered levels of growth factors, adipocytokines, and various hormones are plausible biological mechanisms. In addition, obesity has been shown to have an impact on recurrence, treatment success, and overall survival. There are some reports, although the evidence is not conclusive, that weight loss and lifestyle changes such as dietary modification and physical activity can reduce the risk of colorectal cancer. The understanding that obesity is a potentially modifiable risk factor that can affect the incidence and prognosis of colorectal cancer is crucial knowledge that can have an impact on the prevention and treatment of the condition.

世界范围内肥胖的流行率显著上升,这一趋势在未来几年可能会持续下去。有大量证据表明,肥胖在结直肠癌的发展中起着至关重要的作用。流行病学数据一直表明肥胖和结直肠癌之间存在相关性。胰岛素抵抗、高胰岛素血症、慢性炎症、生长因子、脂肪细胞因子和各种激素水平的改变是可能的生物学机制。此外,肥胖已被证明对复发、治疗成功和总体生存有影响。虽然没有确凿的证据,但也有一些报道称,减肥和改变生活方式,如饮食调整和体育锻炼,可以降低患结直肠癌的风险。肥胖是影响结直肠癌发病率和预后的潜在可改变的危险因素,这一认识对预防和治疗结直肠癌至关重要。
{"title":"[Obesity and Colorectal Cancer].","authors":"Jundeok Lee,&nbsp;Su Young Kim","doi":"10.4166/kjg.2023.083","DOIUrl":"https://doi.org/10.4166/kjg.2023.083","url":null,"abstract":"<p><p>The prevalence of obesity has increased significantly worldwide, and this trend is likely to continue in the coming years. There is substantial evidence that obesity plays a crucial role in the development of colorectal cancer. Epidemiological data have consistently demonstrated a correlation between obesity and colorectal cancer. Insulin resistance, hyperinsulinemia, chronic inflammation, altered levels of growth factors, adipocytokines, and various hormones are plausible biological mechanisms. In addition, obesity has been shown to have an impact on recurrence, treatment success, and overall survival. There are some reports, although the evidence is not conclusive, that weight loss and lifestyle changes such as dietary modification and physical activity can reduce the risk of colorectal cancer. The understanding that obesity is a potentially modifiable risk factor that can affect the incidence and prognosis of colorectal cancer is crucial knowledge that can have an impact on the prevention and treatment of the condition.</p>","PeriodicalId":22736,"journal":{"name":"The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi","volume":"82 2","pages":"63-72"},"PeriodicalIF":0.6,"publicationDate":"2023-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10104480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Diet on Colorectal Cancer Progression and Prevention: From Nutrients to Neoplasms. 饮食对大肠癌进展和预防的影响:从营养到肿瘤。
IF 0.6 Q3 Medicine Pub Date : 2023-08-25 DOI: 10.4166/kjg.2023.079
Sang Hoon Kim, Dong Hwan Park, Yun Jeong Lim

Colorectal cancer (CRC), one of the most common cancers worldwide, continues to increase in incidence and mortality rates. This trend is closely linked to changes in dietary habits, which are major risk factors for colorectal cancer. The increase in the incidence of CRC in countries previously considered low-risk and with low socioeconomic status is most likely due to lifestyle and dietary changes. Understanding the influence of dietary factors on the onset of colorectal cancer is essential for prevention and treatment. This review explores the complex interplay between dietary factors and colorectal cancer, focusing on the key nutrients and dietary habits that influence disease onset and progression. The impact of diet on colorectal microbiota and the influence of diet on early-onset colorectal cancer are also reviewed, reviewing recent research on how dietary interventions affect the treatment and recurrence of colorectal cancer. Finally, the future research directions for developing and applying effective dietary intervention strategies are discussed.

结直肠癌(CRC)是世界上最常见的癌症之一,其发病率和死亡率持续上升。这一趋势与饮食习惯的改变密切相关,而饮食习惯是结直肠癌的主要危险因素。在以前被认为是低风险和低社会经济地位的国家,结直肠癌发病率的增加很可能是由于生活方式和饮食的改变。了解饮食因素对结直肠癌发病的影响对于预防和治疗是至关重要的。本文探讨了饮食因素与结直肠癌之间的复杂相互作用,重点关注影响疾病发生和进展的关键营养素和饮食习惯。综述了饮食对结直肠微生物群的影响以及饮食对早发性结直肠癌的影响,综述了近期饮食干预对结直肠癌治疗和复发的影响。最后,对今后开发和应用有效饮食干预策略的研究方向进行了展望。
{"title":"Impact of Diet on Colorectal Cancer Progression and Prevention: From Nutrients to Neoplasms.","authors":"Sang Hoon Kim,&nbsp;Dong Hwan Park,&nbsp;Yun Jeong Lim","doi":"10.4166/kjg.2023.079","DOIUrl":"https://doi.org/10.4166/kjg.2023.079","url":null,"abstract":"<p><p>Colorectal cancer (CRC), one of the most common cancers worldwide, continues to increase in incidence and mortality rates. This trend is closely linked to changes in dietary habits, which are major risk factors for colorectal cancer. The increase in the incidence of CRC in countries previously considered low-risk and with low socioeconomic status is most likely due to lifestyle and dietary changes. Understanding the influence of dietary factors on the onset of colorectal cancer is essential for prevention and treatment. This review explores the complex interplay between dietary factors and colorectal cancer, focusing on the key nutrients and dietary habits that influence disease onset and progression. The impact of diet on colorectal microbiota and the influence of diet on early-onset colorectal cancer are also reviewed, reviewing recent research on how dietary interventions affect the treatment and recurrence of colorectal cancer. Finally, the future research directions for developing and applying effective dietary intervention strategies are discussed.</p>","PeriodicalId":22736,"journal":{"name":"The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi","volume":"82 2","pages":"73-83"},"PeriodicalIF":0.6,"publicationDate":"2023-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10106436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
[Gut Microbiome and Colorectal Cancer]. [肠道微生物群与结直肠癌]。
IF 0.6 Q3 Medicine Pub Date : 2023-08-25 DOI: 10.4166/kjg.2023.089
Tae-Geun Gweon

Colorectal cancer (CRC) is one of the most common cancers in Korea. A majority of CRCs are caused by progressive genomic alterations referred to as the adenoma-carcinoma sequence. The factors that may increase the risk of CRC include obesity and consumption of a high-fat diet, red meat, processed meat, and alcohol. Recently, the role of gut microbiota in the formation, progression and treatment of CRCs has been investigated in depth. An altered gut microbiota can drive carcinogenesis and cause the development of CRC. Studies have also shown the role of gut microbiota in the prevention of CRC and the impact of therapies involving gut microbiota on CRC. Herein, we summarize the current understanding of the role of the gut microbiota in the development of CRC and its therapeutic potential, including the prevention of CRC and in enhancing efficacy of chemotherapy and immunotherapy.

结直肠癌(CRC)是韩国最常见的癌症之一。大多数crc是由称为腺瘤-癌序列的进行性基因组改变引起的。可能增加结直肠癌风险的因素包括肥胖和食用高脂肪饮食、红肉、加工肉类和酒精。近年来,肠道菌群在CRCs的形成、发展和治疗中的作用得到了深入的研究。肠道菌群的改变可以驱动癌变并导致结直肠癌的发展。研究还表明肠道微生物群在预防结直肠癌中的作用以及涉及肠道微生物群的治疗对结直肠癌的影响。在此,我们总结了目前对肠道微生物群在结直肠癌发展中的作用及其治疗潜力的理解,包括预防结直肠癌和提高化疗和免疫治疗的疗效。
{"title":"[Gut Microbiome and Colorectal Cancer].","authors":"Tae-Geun Gweon","doi":"10.4166/kjg.2023.089","DOIUrl":"https://doi.org/10.4166/kjg.2023.089","url":null,"abstract":"<p><p>Colorectal cancer (CRC) is one of the most common cancers in Korea. A majority of CRCs are caused by progressive genomic alterations referred to as the adenoma-carcinoma sequence. The factors that may increase the risk of CRC include obesity and consumption of a high-fat diet, red meat, processed meat, and alcohol. Recently, the role of gut microbiota in the formation, progression and treatment of CRCs has been investigated in depth. An altered gut microbiota can drive carcinogenesis and cause the development of CRC. Studies have also shown the role of gut microbiota in the prevention of CRC and the impact of therapies involving gut microbiota on CRC. Herein, we summarize the current understanding of the role of the gut microbiota in the development of CRC and its therapeutic potential, including the prevention of CRC and in enhancing efficacy of chemotherapy and immunotherapy.</p>","PeriodicalId":22736,"journal":{"name":"The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi","volume":"82 2","pages":"56-62"},"PeriodicalIF":0.6,"publicationDate":"2023-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10104474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Solitary Fibrous Tumors of the Mesocolon: A Report of Two Cases and Review of Literature. 结肠系膜孤立性纤维性肿瘤2例报告并文献复习。
IF 0.6 Q3 Medicine Pub Date : 2023-08-25 DOI: 10.4166/kjg.2023.053
Madhur M Pardasani, Phani Kumar Nekarakanti, Bheerappa Nagari, Surya Ramachandra Varma Gunturi, Ashish Kumar Bansal, Shantiveer G Uppin

Solitary fibrous tumors (SFTs) are an uncommon group of neoplasms. The visceral pleura is the most common site of origin of these tumors. The colonic mesentery is an unusual site of origin of SFTs. A pre-operative diagnosis of SFT is challenging as there are no pathognomonic clinical or radiological signs. Most patients reported thus far were diagnosed post-operatively with the aid of immunohistochemical markers. Complete surgical excision is the treatment of choice for SFTs. Recurrences are uncommon. However, they can occasionally show aggressive behavior. In this report, we describe two cases of rare colonic mesentery SFTs.

孤立性纤维性肿瘤是一种罕见的肿瘤。内脏胸膜是这些肿瘤最常见的起源部位。结肠肠系膜是一种罕见的SFTs发病部位。术前诊断SFT是具有挑战性的,因为没有病理特征的临床或放射学征象。迄今为止报道的大多数患者都是在术后借助免疫组织化学标志物进行诊断的。完全手术切除是SFTs的治疗选择。复发是罕见的。然而,它们偶尔会表现出攻击性行为。在此报告中,我们描述了两例罕见的结肠肠系膜SFTs。
{"title":"Solitary Fibrous Tumors of the Mesocolon: A Report of Two Cases and Review of Literature.","authors":"Madhur M Pardasani,&nbsp;Phani Kumar Nekarakanti,&nbsp;Bheerappa Nagari,&nbsp;Surya Ramachandra Varma Gunturi,&nbsp;Ashish Kumar Bansal,&nbsp;Shantiveer G Uppin","doi":"10.4166/kjg.2023.053","DOIUrl":"https://doi.org/10.4166/kjg.2023.053","url":null,"abstract":"<p><p>Solitary fibrous tumors (SFTs) are an uncommon group of neoplasms. The visceral pleura is the most common site of origin of these tumors. The colonic mesentery is an unusual site of origin of SFTs. A pre-operative diagnosis of SFT is challenging as there are no pathognomonic clinical or radiological signs. Most patients reported thus far were diagnosed post-operatively with the aid of immunohistochemical markers. Complete surgical excision is the treatment of choice for SFTs. Recurrences are uncommon. However, they can occasionally show aggressive behavior. In this report, we describe two cases of rare colonic mesentery SFTs.</p>","PeriodicalId":22736,"journal":{"name":"The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi","volume":"82 2","pages":"96-101"},"PeriodicalIF":0.6,"publicationDate":"2023-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10106434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1